SCHEMBL26847339

SCHEMBL26847339

C=C1N=C(Cc2cccc(CSc3[nH]c(=O)cc(C(F)(F)F)c3C#N)c2)NO1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.46
▸ ALDH1A1 P00352 6/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KMT2A Q03164 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ POLB P06746 3/20 0.37
▸ TNF P01375 1/20 0.37
▸ NOD2 Q9HC29 1/20 0.37
▸ NOD1 Q9Y239 1/20 0.37
▸ TSHR P16473 2/20 0.36
▸ GFER P55789 1/20 0.36
▸ HSD11B1 P28845 3/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ ACMSD Q8TDX5 3/20 0.33
▸ HPGD P15428 5/20 0.33
▸ GAA P10253 4/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847347 0.82 ACMSD (0.42) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL24087894 0.79 KDM4E (0.48) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL23850213 0.77 KDM4E (0.65) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL26847386 0.76 ACMSD (0.46) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20350842 0.75 KDM4E (0.54) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20340200 0.75 KDM4E (0.62) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20340093 0.74 KDM4E (0.48) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL20350867 0.70 KDM4E (0.50) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL26847333 0.69 KDM4E (0.57) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL24088145 0.69 KDM4E (0.62) KDM4EALDH1A1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885MAPT 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback